Le Lézard
Classified in: Health, Business
Subjects: LIC, PET

Gilad&Gilad enters Taiwan with AgmaVet®, a Veterinary Product for Nerve Health


HENDERSON, Nev., March 1, 2020 /PRNewswire-PRWeb/ -- Gilad&Gilad a health science company based in Henderson, Nevada, with core competency in Neuroscience and the exclusive supplier of AgmaVet®, a unique veterinary dietary product for nerve health, has initiated a collaboration with Pet Enjoy Bio-Science Co., Ltd. for distribution in Taiwan.

According to Dr. Gad M. Gilad, CEO of Gilad&Gilad, "The Ministry of Health of Taiwan has issued a permit allowing our collaborating distributor, Pet Enjoy Bio-Science, to import and distribute AgmaVet in Taiwan. Pet Enjoy was founded by a team highly experienced in the veterinary market, very proficient in marketing and sales of superior pet healthcare products in Taiwan and East Asia." Dr. Gilad adds that "this collaboration is part of Gilad&Gilad's ongoing efforts to expand worldwide distribution and sales and allows us to establish presence in this thriving region."

AgmaVet is a novel first-of-its-kind nutraceutical product affording what is surely the best available solution for maintaining healthy, pain-free nerve functions. "Using AgmaVet® to fortify the daily intake of the nutraceutical G-Agmatine® (Gilad&Gilad's proprietary brand of agmatine) provides a safe and most effective solution for nerve resilience, normal sensory functions and nerve-dependent muscle strength, which are cardinal for good quality of life," says Dr. Gilad.

"We are pleased to collaborate with Gilad&Gilad and to be the distributor of AgmaVet in Taiwan," says Mr. PeterTu, General Manager of Pet Enjoy Bio-Science. "There is a growing demand in Taiwan's veterinary pet market for good quality healthcare products and the companion animal health market is expected to grow considerably in the coming years," he adds. "There are over 1,000 active animal clinics in Taiwan and our professional sales team already covers 80% of them. Together with Gilad&Gilad expertise and reputation we are making AgmaVet® readily available to them."

According to export.gov (11/8/2019), the online portal of the International Trade Administration, US Department of Commerce, Taiwan's pet food (dog and cat food) market rallied on import demand, growing by 11 percent to nearly $180 million, more than doubling over the past decade.

About Gilad&Gilad LLC
Gilad&Gilad is a health science company with core competency in Neuroscience. The company has developed the exclusive Agmaceuticals(TM) line of products based on the breakthrough discovery of the neuroprotective properties agmatine. AgmaVet® is the first-of-its-kind nutraceutical for animals containing G-Agmatine® (the best brand of agmatine), with superior effectiveness for healthy nerve functions. - For further information, visit https://ForNerveHealth.com.

About Pet Enjoy Bio-Science
Pet Enjoy Bio-Science is a company based in Taiwan with expertise in marketing, distribution and sales of best solutions to unmet needs of the veterinary clinical practice and of animal healthcare by pet owners. Its mission is to become the best animal healthcare distribution partner in the ASIAN market. - For further information, visit http://www.petenjoy-bio.com.

 

SOURCE Gilad&Gilad


These press releases may also interest you

at 16:28
Dr. Siva Mohan, Co-Founder and Chief Medical Officer of RazorMetrics, an Austin-based drug cost reduction platform, is the Best Entrepreneur - Health Products & Services Status: Silver Stevie Winner from the American Business Awards. The Stevie®...

at 16:20
The Board of Directors of Revvity , today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on August 9, 2024 to all shareholders of record at the close of business on July 19, 2024. About Revvity ...

at 16:20
Edwards Lifesciences today reported financial results for the quarter ended March 31, 2024. Highlights and Outlook Q1 sales grew 10% on a reported and constant currency1 basis to $1.6 billion Q1 TAVR sales grew 6%; constant currency sales...

at 16:16
A functional assessment of Bacillus subtilis PLSSC (SEBtilistm) demonstrated its antimicrobial activity and capability to offer health benefits through industrial processing and the digestion process, showing its value-add in functional foods,...

at 16:15
Cronos Group Inc. ("Cronos" or the "Company") will hold its 2024 first quarter earnings conference call on Thursday, May 9, 2024 at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for...

at 16:05
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today...



News published on and distributed by: